HF
ENZ

HRT Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

HRT Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,537
Closed -$11K – 3597
2024
Q4 		$11K Buy
+16,537
New +$17.1K ﹤0.01% 2273
2022
Q1 		– Sell
-17,589
Closed -$56K – 4027
2021
Q4 		$56K Sell
17,589
-110,035
-86% -$375K ﹤0.01% 2829
2021
Q3 		$451K Sell
127,624
-2,461
-2% -$8.21K ﹤0.01% 2090
2021
Q2 		$412K Buy
+130,085
New +$409K ﹤0.01% 1937

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's ENZ Position: Q1 2025 in Review

HRT Financial sold out of Enzo Biochem, Inc. (ENZ) in Q1 2025, closing a stake of 16,537 shares — an estimated $11K sold.

HRT Financial first reported a position in ENZ in Q2 2021 and held it in 4 quarters. The position peaked at $451K in Q3 2021. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2025.

  • HRT Financial reported no remaining Enzo Biochem, Inc. position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 16,537 Enzo Biochem, Inc. shares in Q1 2025, an estimated $11K.
  • HRT Financial first reported a position in Enzo Biochem, Inc. in Q2 2021 and held it in 4 quarters.
  • HRT Financial's Enzo Biochem, Inc. position peaked at $451K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.